Unlearn builds machine-learning platforms to create biological digital twins for the healthcare and pharmaceutical industries. It develops generative machine learning methods to predict individual health outcomes and accelerate clinical innovation. It connects with biopharma companies and regulators to ensure its methods meet scientific and regulatory standards.